Evidence map›Paper›PMID 28798802›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2017

Prescribed Renoprotective Chinese Herbal Medicines Were Associated with a Lower Risk of All-Cause and Disease-Specific Mortality among Patients with Chronic Kidney Disease: A Population-Based Follow-Up Study in Taiwan.

Chuan-Fa Hsieh, Huan-Cheng Chang, Song-Lih Huang, Chien-Lung Chen, Wei-Ta Chen, Chen-Chang Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Ethyl Acetate Fractions ofInternational journal of molecular sciences · 2024
    Article
  3. Jian-Pi-Yi-Shen Formula Alleviates Chronic Kidney Disease in Two Rat Models by Modulating QPRT/NADEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chuan-Fa HsiehDepartment of Medical Education and Research, Taiwan Landseed Hospital, No. 77, Guangtai Rd., Pingzhen Dist., Taoyuan 32449, Taiwan.
Huan-Cheng ChangDivision of Nephrology, Department of Medicine, Taiwan Landseed Hospital, No. 77, Guangtai Rd., Pingzhen Dist., Taoyuan 32449, Taiwan.
Song-Lih HuangInstitute of Public Health & Department of Public Health, School of Medicine, National Yang-Ming University, No. 155, Sec. 2, Linong St., Taipei 11221, Taiwan.
Chien-Lung ChenDivision of Nephrology, Department of Medicine, Taiwan Landseed Hospital, No. 77, Guangtai Rd., Pingzhen Dist., Taoyuan 32449, Taiwan.ORCID 0000-0002-4986-2424
Wei-Ta ChenDepartment of Chinese Medicine, Taiwan Landseed Hospital, No. 77, Guangtai Rd., Pingzhen Dist., Taoyuan 32449, Taiwan.
Chen-Chang YangInstitute of Environmental & Occupational Health Sciences, School of Medicine, National Yang-Ming University, No. 155, Sec. 2, Linong St., Taipei 11221, Taiwan.ORCID 0000-0003-1391-8323

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chinese herbal medicines (CHMs) containing aristolochic acid (AA) are associated with chronic kidney disease (CKD), but some prescribed CHMs have been shown to possess renoprotective effects. We conducted a nationwide retrospective cohort study to delineate the role of prescribed CHMs on the CKD progression. Renoprotective CHM (RPCHM) was defined if a CHM contained dong chong xia cao (

Identifiers

PMID28798802
PMCPMC5535732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.